A single-center retrospective analysis of the effect of Radium-223 (Xofigo) on pancytopenia in patients with metastatic castration-resistant prostate cancer. Article
Full Text via DOI: 10.1200/JCO.2019.37.15_suppl.e16546
Web of Science: 000487345801577